These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 31063089)

  • 1. Modelling diverse sources of Clostridium difficile in the community: importance of animals, infants and asymptomatic carriers.
    McLure A; Clements ACA; Kirk M; Glass K
    Epidemiol Infect; 2019 Jan; 147():e152. PubMed ID: 31063089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New insights into transmission of Clostridium difficile infection-narrative review.
    Durovic A; Widmer AF; Tschudin-Sutter S
    Clin Microbiol Infect; 2018 May; 24(5):483-492. PubMed ID: 29427800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clostridium difficile classification overestimates hospital-acquired infections.
    McLure A; Clements ACA; Kirk M; Glass K
    J Hosp Infect; 2018 Aug; 99(4):453-460. PubMed ID: 29258917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Healthcare-Associated Clostridium difficile Infections are Sustained by Disease from the Community.
    McLure A; Clements ACA; Kirk M; Glass K
    Bull Math Biol; 2017 Oct; 79(10):2242-2257. PubMed ID: 28776206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clostridium difficile and One Health.
    Lim SC; Knight DR; Riley TV
    Clin Microbiol Infect; 2020 Jul; 26(7):857-863. PubMed ID: 31682985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Whole genome sequencing of toxigenic Clostridium difficile in asymptomatic carriers: insights into possible role in transmission.
    Halstead FD; Ravi A; Thomson N; Nuur M; Hughes K; Brailey M; Oppenheim BA
    J Hosp Infect; 2019 Jun; 102(2):125-134. PubMed ID: 30359648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seasonality and community interventions in a mathematical model of Clostridium difficile transmission.
    McLure A; Furuya-Kanamori L; Clements ACA; Kirk M; Glass K
    J Hosp Infect; 2019 Jun; 102(2):157-164. PubMed ID: 30880267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Clostridium difficile Ribotypes Circulating in Australian Hospitals and Communities.
    Furuya-Kanamori L; Riley TV; Paterson DL; Foster NF; Huber CA; Hong S; Harris-Brown T; Robson J; Clements AC
    J Clin Microbiol; 2017 Jan; 55(1):216-225. PubMed ID: 27807147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential sources of Clostridium difficile in human infection.
    Bauer MP; Kuijper EJ
    Infect Dis Clin North Am; 2015 Mar; 29(1):29-35. PubMed ID: 25582646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clostridium difficile Whole Genome Sequencing Reveals Limited Transmission Among Symptomatic Children: A Single-Center Analysis.
    Kociolek LK; Gerding DN; Espinosa RO; Patel SJ; Shulman ST; Ozer EA
    Clin Infect Dis; 2018 Jul; 67(2):229-234. PubMed ID: 29370348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiological model for Clostridium difficile transmission in healthcare settings.
    Lanzas C; Dubberke ER; Lu Z; Reske KA; Gröhn YT
    Infect Control Hosp Epidemiol; 2011 Jun; 32(6):553-61. PubMed ID: 21558767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantifying Transmission of Clostridium difficile within and outside Healthcare Settings.
    Durham DP; Olsen MA; Dubberke ER; Galvani AP; Townsend JP
    Emerg Infect Dis; 2016 Apr; 22(4):608-16. PubMed ID: 26982504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced surveillance of Clostridium difficile infection occurring outside hospital, England, 2011 to 2013.
    Fawley WN; Davies KA; Morris T; Parnell P; Howe R; Wilcox MH;
    Euro Surveill; 2016 Jul; 21(29):. PubMed ID: 27487436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disease transmission model for community-associated Clostridium difficile infection.
    Otten AM; Reid-Smith RJ; Fazil A; Weese JS
    Epidemiol Infect; 2010 Jun; 138(6):907-14. PubMed ID: 20092667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clostridium difficile infection in the community: a zoonotic disease?
    Hensgens MP; Keessen EC; Squire MM; Riley TV; Koene MG; de Boer E; Lipman LJ; Kuijper EJ;
    Clin Microbiol Infect; 2012 Jul; 18(7):635-45. PubMed ID: 22536816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zero prevalence of Clostridium difficile in wild passerine birds in Europe.
    Bandelj P; Trilar T; Racnik J; Zadravec M; Pirš T; Avbersek J; Micunovic J; Ocepek M; Vengust M
    FEMS Microbiol Lett; 2011 Aug; 321(2):183-5. PubMed ID: 21658108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clostridium difficile spores: a major threat to the hospital environment.
    Barra-Carrasco J; Paredes-Sabja D
    Future Microbiol; 2014; 9(4):475-86. PubMed ID: 24810347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Asymptomatic carriage of toxigenic Clostridium difficile by hospitalized patients.
    Guerrero DM; Becker JC; Eckstein EC; Kundrapu S; Deshpande A; Sethi AK; Donskey CJ
    J Hosp Infect; 2013 Oct; 85(2):155-8. PubMed ID: 23954113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing the effect of patient screening and isolation on curtailing Clostridium difficile infection in hospital settings.
    Maghdoori S; Moghadas SM
    BMC Infect Dis; 2017 Jun; 17(1):384. PubMed ID: 28577357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Detecting and Isolating Clostridium difficile Carriers at Hospital Admission on the Incidence of C difficile Infections: A Quasi-Experimental Controlled Study.
    Longtin Y; Paquet-Bolduc B; Gilca R; Garenc C; Fortin E; Longtin J; Trottier S; Gervais P; Roussy JF; Lévesque S; Ben-David D; Cloutier I; Loo VG
    JAMA Intern Med; 2016 Jun; 176(6):796-804. PubMed ID: 27111806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.